4.92
전일 마감가:
$5.23
열려 있는:
$5.14
하루 거래량:
557.32K
Relative Volume:
0.74
시가총액:
$294.69M
수익:
-
순이익/손실:
$-44.80M
주가수익비율:
-6.56
EPS:
-0.75
순현금흐름:
$-30.67M
1주 성능:
-4.28%
1개월 성능:
-14.29%
6개월 성능:
+75.09%
1년 성능:
-5.02%
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
명칭
Aldeyra Therapeutics Inc
전화
781-761-4904
주소
131 HARTWELL AVENUE, LEXINGTON, MA
ALDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ALDX
Aldeyra Therapeutics Inc
|
4.92 | 314.04M | 0 | -44.80M | -30.67M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-03 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-04-02 | 재개 | H.C. Wainwright | Buy |
| 2022-04-27 | 재개 | H.C. Wainwright | Buy |
| 2021-02-08 | 개시 | H.C. Wainwright | Buy |
| 2020-12-16 | 개시 | Berenberg | Buy |
| 2020-10-30 | 개시 | Jefferies | Buy |
| 2020-10-16 | 개시 | BTIG Research | Buy |
| 2020-09-22 | 개시 | Alliance Global Partners | Buy |
| 2020-05-12 | 개시 | Oppenheimer | Outperform |
| 2018-12-04 | 개시 | Citigroup | Buy |
| 2018-09-26 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-09-13 | 개시 | Janney | Buy |
| 2018-01-26 | 개시 | Seaport Global Securities | Buy |
| 2016-09-26 | 개시 | H.C. Wainwright | Buy |
| 2016-07-01 | 개시 | Stifel | Buy |
| 2015-07-01 | 개시 | Canaccord Genuity | Buy |
| 2015-03-25 | 개시 | Chardan Capital Markets | Buy |
| 2015-03-20 | 재확인 | H.C. Wainwright | Buy |
| 2014-11-18 | 개시 | H.C. Wainwright | Buy |
| 2014-06-19 | 개시 | Aegis Capital | Buy |
모두보기
Aldeyra Therapeutics Inc 주식(ALDX)의 최신 뉴스
Can a trend reversal in Aldeyra Therapeutics Inc. lead to recoveryWall Street Watch & Verified Trade Idea Suggestions - newser.com
Sentiment analysis tools applied to Aldeyra Therapeutics Inc.Weekly Market Summary & Real-Time Price Movement Reports - newser.com
Why analysts upgrade Aldeyra Therapeutics Inc. stockJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Live market analysis of Aldeyra Therapeutics Inc.July 2025 Decliners & Accurate Technical Buy Alerts - newser.com
Is Aldeyra Therapeutics Inc. stock dividend yield sustainableInsider Buying & Stock Portfolio Risk Control - newser.com
Aldeyra Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Selloffs & Reliable Trade Execution Plans - newser.com
Evaluating Aldeyra Therapeutics Inc. with trendline analysis2025 Performance Recap & Fast Entry High Yield Tips - newser.com
Smart tools for monitoring Aldeyra Therapeutics Inc.’s price action - newser.com
How to interpret RSI for Aldeyra Therapeutics Inc. stockJuly 2025 Action & Daily Growth Stock Investment Tips - newser.com
Analyzing net buyer seller activity in Aldeyra Therapeutics Inc.Portfolio Gains Summary & Safe Entry Zone Identification - newser.com
Published on: 2025-11-03 21:46:12 - newser.com
Aldeyra’s Experimental Drug Shows Promising Results In Mid-Stage Alcohol Hepatitis Trial - MSN
Applying Wyckoff theory to Aldeyra Therapeutics Inc. stockWeekly Loss Report & Weekly High Return Stock Forecasts - newser.com
Is Aldeyra Therapeutics Inc. stock resilient to inflationWeekly Market Outlook & Technical Confirmation Trade Alerts - newser.com
How Aldeyra Therapeutics Inc. stock performs in weak economyJuly 2025 Intraday Action & Community Consensus Trade Alerts - newser.com
Intraday pattern recognizer results for Aldeyra Therapeutics Inc.2025 Top Decliners & Growth Focused Stock Reports - newser.com
Will Aldeyra Therapeutics Inc. stock split again soonShort Setup & Smart Money Movement Alerts - newser.com
Why Aldeyra Therapeutics Inc. stock could see breakout soonJuly 2025 Market Mood & Breakout Confirmation Alerts - newser.com
Automated trading signals detected on Aldeyra Therapeutics Inc.Market Trend Review & Free Reliable Trade Execution Plans - newser.com
Combining price and volume data for Aldeyra Therapeutics Inc.Stock Surge & Safe Capital Allocation Plans - newser.com
Is Aldeyra Therapeutics Inc. stock attractive for ETFsIndex Update & Weekly High Momentum Picks - newser.com
Understanding Aldeyra Therapeutics Inc.’s price movementTrade Entry Report & Reliable Price Action Trade Plans - newser.com
Is Aldeyra Therapeutics Inc. stock affected by interest rate hikes2025 EndofYear Setup & AI Enhanced Execution Alerts - newser.com
What insider trading reveals about Aldeyra Therapeutics Inc. stock2025 Momentum Check & High Win Rate Trade Alerts - newser.com
Aldeyra refocuses pipeline on next-gen RASP modulators despite positive phase II success - Indian Pharma Post
Catalyst Monitor Outlook, Q4 2025 Report: Pipeline Advances with Key Approvals and Trials: Featuring Cytokinetics's Aficamten, Aldeyra's Reproxalap, GSK's Depemokimab - Yahoo Finance
Aldeyra Therapeutics Inc (ALDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):